Home / Tag Archives: metabolic health (page 6)

Tag Archives: metabolic health

Aiming for MASH Resolution: How to Use GLP‑1s in Liver‑First Diabetes Care

A doctor holding a liver model with GLP-1 injection tools, healthy food, and a glucometer, symbolizing GLP‑1 MASH treatment in diabetes care.

What if the key to resolving both diabetes and liver disease lies in a single therapeutic approach? As rates of metabolic dysfunction-associated steatohepatitis (MASH) rise among people with type 2 diabetes, many clinicians are rethinking how they prioritize treatment. Rather than treating glucose and liver health in silos, combining therapies …

Read More »

Inside the ADA 2026 Guidelines: A New Cardiometabolic Roadmap for Diabetes Care

Medical tools including a glucose meter, stethoscope, and ADA 2026 Guidelines clipboard, with digital icons representing cardiometabolic health

The updated ADA 2026 standards represent a major shift in how clinicians approach diabetes management. Rather than focusing solely on lowering A1C, these new recommendations promote a broader, holistic strategy that integrates cardiovascular, kidney, and metabolic (CKM) risk management into everyday care. This article breaks down the key updates and …

Read More »

Can GLP‑1s Help Curb Alcohol Use? What Diabetes Clinicians Should Know

GLP-1 injection pen beside glasses of alcohol on a doctor's desk, representing potential alcohol use reduction benefits.

Early research suggests GLP‑1 drugs may reduce alcohol intake by dampening reward signaling and hedonic hunger, sparking interest among diabetes clinicians about the potential of GLP-1 alcohol use reduction. While findings so far are promising, understanding the nuances of the evidence is essential when talking with patients. This article explores …

Read More »

Why Screening for Sleep Apnea Should Be Standard in Diabetes Care

A CPAP nasal mask and tubing placed beside diabetes and sleep apnea screening questionnaires, including the STOP-Bang tool.

In clinical practice, the link between sleep apnea diabetes screening and improved patient outcomes is becoming increasingly clear. Obstructive sleep apnea (OSA) is both a contributor to and a consequence of poor glycemic control, yet it remains under‑recognized in diabetes management. If clinicians fail to screen for sleep apnea in …

Read More »